Lung Large Cell Neuroendocrine Carcinoma: A Rare but Aggressive Disease Intro

Panelists discuss how lung large cell neuroendocrine carcinoma (LCNEC) is characterized by its biology, incidence, risk factors, clinical presentation, and prognosis, while addressing the challenges, unmet needs, and the trial data required to guide testing and treatment guidelines for this rare cancer.

Now Viewing

EP: 1.Lung Large Cell Neuroendocrine Carcinoma: A Rare but Aggressive Disease Intro

EP: 2.An Overview of the Molecular Characterization of Lung LCNEC

EP: 3.The Pathological Diagnosis of Lung LCNEC

EP: 4.Biomarker Testing Strategies for Lung LCNEC

EP: 5.Biopsy Best Practices: Diagnosing Lung LCNEC

EP: 6.Lung LCNEC Diagnostic Challenges

EP: 7.A Multidisciplinary Approach to Managing Lung LCNEC

EP: 8.Lung LCNEC Disease Histology and Prognosis

1. Dr. Dietrich to provide a brief overview of lung LCNEC:

• Biology
• Incidence
• Risk factors
• Presentation
• Prognosis

1. Dr. Yang to Dr. Dietrich:

• How often do you see these patients in your practice?
• What challenges and unmet needs surround lung LCNEC?
• What trial data are needed to inform development of guidelines around LCNEC testing and treatment?

Related Videos